openPR Logo
Press release

Chinese Medical Team Achieves Functional Cure in 24 Cases of Type 1 Diabetes Mellitus (T1DM) Using Holistic Integrative Medicine (HIM)

08-15-2025 06:26 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: SHENZHEN HMEDIUM INFORMATION TECHNOLOGY CO.,LTD
Chinese Medical Team Achieves Functional Cure in 24 Cases of Type

Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024, they have successfully helped 24 patients with Type 1 diabetes mellitus (T1DM) discontinue insulin therapy through holistic integrative medicine (HIM)-an optimized combination of traditional Chinese and Western medicine-thereby achieving a functional cure. The longest duration of insulin discontinuation has reached 14 months. This breakthrough offers new hope for global T1DM treatment and marks a remarkable advance in integrated Chinese and Western medicine for autoimmune diseases..

Breakthrough Therapy: Precision Intervention through HIM

T1DM is an autoimmune disorder characterized by the destruction of beta cells, resulting in an absolute deficiency of insulin secretion. Conventional medicine holds that patients require lifelong insulin injections. However, Professor An's team employed the HIM model combining holistic traditional Chinese medicine (TCM), orthomolecular medicine, functional medicine, and lifestyle medicine focused on immune blockade and metabolic balance, alongside endocrinology-specialized precision remote digital healthcare, to successfully restore islet function and enable insulin discontinuation.

The core of this treatment protocol lies in multidisciplinary collaboration, including precision diagnostics using mass spectrometry platforms to identify the immunological causes of T1DM for targeted etiological treatment; immune regulation through molecular nutrition and TCM to modulate abnormal immune responses and reduce autoimmune attacks on pancreatic islet cells; metabolic repair by improving the body's microenvironment and promoting islet function recovery via TCM acupuncture, herbal medicine, and nutritional interventions; and precision monitoring that employs artificial intelligence to dynamically analyze patients' blood glucose and immune markers, allowing personalized adjustments to treatment strategies. Patients typically require only 3 to 5 days of hospitalization before discharge.

Image: https://www.globalnewslines.com/uploads/2025/08/fb183cb053d458025cfc49891d151061.jpg

(Professor An Chiying inspects patients with type 1 diabetes)

Clinical Data: 24 Patients Discontinued Insulin Therapy

Over a two-year clinical observation period, the team intervened in 70 patients with T1DM, among whom 24 patients (34%) completely discontinued insulin use. These patients maintained stable blood glucose levels (HbA1c < 7%) and showed significant recovery of islet function as evidenced by C-peptide testing. Currently, these patients only require dietary management and regular follow-up, without reliance on exogenous insulin.

Professor An Chiying emphasized, "Functional cure refers to the partial restoration of islet function sufficient to meet normal metabolic demands, achieved through immune blockade, intestinal mucosal repair, and gut microbiota reconstruction. Patients diagnosed early with T1DM who have a C-peptide level above 0.5 ng/ml can stop insulin, while those with insufficient islet function can significantly reduce insulin dosage once blood glucose levels are stabilized."

National Academician's Evaluation: Pioneering a New Treatment Paradigm

Academician Fan Daiming of the Chinese Academy of Engineering (CAE) and pioneer of HIM in China commented, "The results achieved by this Chinese team challenge the traditional view that T1DM requires lifelong medication. The synergistic effects of HIM deserve the attention of peers worldwide and open a new clinical treatment paradigm for T1DM."

Background

There are approximately 9 million T1DM patients globally. Traditional treatment costs exceed RMB 10,000 annually, and patient prognoses remain unsatisfactory with uncontrollable risks of complications. The widespread adoption of HIM health management programs could significantly reduce both the financial and health burdens on patients.

Shenzhen Hengsheng Hospital Chronic Disease Integrative Medicine Center/Diabetes Naturopathic Center
Media Contact
Company Name: ShanghaiFosunGroup-ShenzhenHangSengHospital
Contact Person: Anchiying
Email: Send Email [http://www.universalpressrelease.com/?pr=chinese-medical-team-achieves-functional-cure-in-24-cases-of-type-1-diabetes-mellitus-t1dm-using-holistic-integrative-medicine-him]
Phone: +86-755-27796031
City: Shenzhen
Country: China
Website: https://www.hsyy.com.cn/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chinese Medical Team Achieves Functional Cure in 24 Cases of Type 1 Diabetes Mellitus (T1DM) Using Holistic Integrative Medicine (HIM) here

News-ID: 4146498 • Views:

More Releases from Getnews

Adam Whitelock: Setting the Standard on Christchurch's East Side
Adam Whitelock: Setting the Standard on Christchurch's East Side
Image: https://www.globalnewslines.com/uploads/2025/10/1761738399.jpg Adam Whitelock, Bayleys Christchurch agent, on-site in Sumner. Quote: "I treat every property as unique. Knowing the market, understanding buyers, and presenting homes effectively-that's how you achieve the best results." - Adam Whitelock Adam Whitelock, a results-driven Bayleys Christchurch agent based in Sumner, continues to set the standard for East Side real estate with his clear communication, local expertise, and results-focused approach. Adam Whitelock Raises the Standard for Real Estate Performance
Soumadeep Mondal's PRessence 360 Embarks on Global Expansion, Establishing a Network of Branded Partner Agencies Across Emerging and Established Markets
Soumadeep Mondal's PRessence 360 Embarks on Global Expansion, Establishing a Net …
Image: https://www.globalnewslines.com/uploads/2025/10/1761759226.jpg "What we're creating isn't expansion for attention's sake. It's a quiet architecture of influence - designed to last." - Soumadeep Mondal Co-founded by Soumadeep Mondal and Austin Clark, PRessence 360 is solidifying its position as a global media infrastructure firm-expanding through a selective network of branded partner agencies built on proprietary systems, strategic leadership, and operational precision. Image: https://www.globalnewslines.com/uploads/2025/10/324d9c3efb837af369a0b1cb27af416d.jpg PRessence 360 has entered a decisive phase of global expansion, signaling its evolution
Soumadeep Mondal's PRessence 360 Announces Strategic Global Expansion as Network of Branded Partner Agencies Scales Across Key Markets
Soumadeep Mondal's PRessence 360 Announces Strategic Global Expansion as Network …
Image: https://www.globalnewslines.com/uploads/2025/10/1761757821.jpg "We're not building more agencies. We're building infrastructure-an ecosystem that defines how authority and influence scale globally." - Soumadeep Mondal, Co-Founder, PRessence 360 Under the leadership of Co-founders Soumadeep Mondal and Austin Clark, PRessence 360 is evolving from a premier Public Relations consultancy into a global media infrastructure firm-scaling its influence through a growing network of precision-run partner agencies unified under its proprietary systems and strategic framework. PRessence 360 has entered
Folsom Foodie Supper Club Debuts with Chef-Led Launch Dinner at Scott's Seafood Roundhouse on October 30
Folsom Foodie Supper Club Debuts with Chef-Led Launch Dinner at Scott's Seafood …
Inaugural multi-course menu from Executive Chef Nick Blessing celebrates Northern California flavors with modern, farm-to-fork technique. Image: https://authoritypresswire.com/wp-content/uploads/2025/10/Folsom-Foodie-1.png FOLSOM, CA - October 29, 2025 - The newly launched Folsom Foodie Supper Club will host its first official event tonight at Scott's Seafood Roundhouse in Historic Folsom-a chef-curated, small-format tasting experience designed to showcase the region's ingredients, makers, and culinary talent. The launch dinner features an original menu by Executive Chef Nick Blessing,

All 5 Releases


More Releases for T1DM

New Book "Dia-doodles" Offers a Bold, Artistic Look at Life with Type 1 Diabetes
Image: https://www.globalnewslines.com/uploads/2025/09/1758040882.jpg A Powerful Fusion of Memoir, Medicine, and Art Aims to Educate, Inspire, and Build Global Empathy for the T1DM Community In a groundbreaking new release, Dia-doodles by C. Tufan gives readers a deeply human, visually compelling look into the lived experience of Type 1 Diabetes (T1DM), a condition often misunderstood and surrounded by stigma. Drawing from both personal and professional experience, Tufan, a practicing pediatric doctor and T1DM patient herself,
Chinese Medical Team Achieves Functional Cure in Twenty-Four Cases of Type 1 Dia …
Shenzhen - August 18, 2025 - Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024, they have successfully helped 24 patients with Type 1 diabetes mellitus (T1DM) discontinue insulin therapy through holistic integrative medicine (HIM)-an optimized combination of traditional Chinese and Western medicine-thereby achieving a functional cure. The longest duration of insulin discontinuation has reached 14 months. This breakthrough
Inclusion of Type 1 Diabetes Mellitus (T1DM) in National NCD Programme
13th August 2024, 10:00 am: People to People Health Foundation, in collaboration with DEESHA (Diabetes [Type 1] Education & Empowerment Strategic Health Alliance), hosted a pivotal roundtable discussion. under the esteemed guidance of the. This significant event marked a major step forward in the national health agenda, focusing on the critical inclusion of Type 1 Diabetes Mellitus (T1DM) in the National Non-Communicable Diseases (NCD) Programme. The roundtable brought together over
PolTREG has presented an innovative method for the treatment of type 1 diabetes …
Researchers from the Polish Consortium PolTREG and STRATEGMED TREGS presented the initial results of phase II trial assessing regulatory T cells (Tregs) during the 80th Conference of the American Diabetes Association (ADA). The Polish company operates in the same area as the American company Provention Bio, which has presented a method for the treatment of presymptomatic patients with type 1 diabetes mellitus (T1DM) during the same event. The American company’s
Recent Study on Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets …
Researchmoz added Most up-to-date research on "Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations" to its huge collection of research reports. Type 1 Diabetes Mellitus (T1DM) is a chronic, progressive and serious disease characterized by a destruction or failure of insulin-secreting pancreatic beta cells, usually as a result of an autoimmune response. The resulting insulin deficiency
Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innov …
ResearchMoz added Latest Research Report titled " Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations " to it's Large Report database. Type 1 Diabetes Mellitus (T1DM) is a chronic, progressive and serious disease characterized by a destruction or failure of insulin-secreting pancreatic beta cells, usually as a result of an autoimmune response. The resulting insulin deficiency